Harpoon Therapeutics, Inc. (HARP): Price and Financial Metrics
GET POWR RATINGS... FREE!
HARP Stock Price Chart Interactive Chart >
HARP Price/Volume Stats
| Current price | $2.08 | 52-week high | $22.74 |
| Prev. close | $1.97 | 52-week low | $1.73 |
| Day low | $1.89 | Volume | 271,700 |
| Day high | $2.12 | Avg. volume | 320,686 |
| 50-day MA | $3.23 | Dividend yield | N/A |
| 200-day MA | $5.85 | Market Cap | 68.81M |
Harpoon Therapeutics, Inc. (HARP) Company Bio
Harpoon Therapeutics, Inc. develops antibody therapies to treat cancer patients. It develops a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets. The company founded by Patrick A. Baeuerle and Luke B. Evnin in 2015 and is headquartered in South San Francisco, CA.
Latest HARP News From Around the Web
Below are the latest news stories about Harpoon Therapeutics Inc that investors may wish to consider to help them evaluate HARP as an investment opportunity.
Harpoon Therapeutics: A First LookHe who will do anything to avoid failure will almost certainly do something worthy of a failure." -Ryan Holiday” Today, we take an in-depth look at a small developmental firm to determine if it might be worth an investment after a recent large sell-off. Our analysis follows in the paragraphs... |
HARP Price Returns
| 1-mo | -7.56% |
| 3-mo | -49.27% |
| 6-mo | -66.12% |
| 1-year | -89.91% |
| 3-year | -82.92% |
| 5-year | N/A |
| YTD | -72.45% |
| 2021 | -54.55% |
| 2020 | 12.31% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...